関連する実験動画
Updated: Sep 10, 2025

14:55
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
Published on: May 12, 2013
60.8K
C9orf72関連ALSにおける反感覚オリゴヌクレオチド療法の分子効果
Zachary T McEachin1, Mingee Chung2, Sabrina A Stratton2
1Department of Human Genetics, Emory University, Atlanta, GA 30322, USA; Department of Cell Biology, Emory University, Atlanta, GA 30322, USA; Laboratory for Translational Cell Biology, Emory University, Atlanta, GA 30322, USA; Goizueta Brain Health Institute Center for Neurodegenerative Diseases, Emory University, Atlanta, GA 30322, USA.
Cell
|August 27, 2025
まとめ
C9orf72に関連したALSに対するアンチセンセスオリゴヌクレオチドBIIB078は,広範囲に分布しているが,主要な中枢神経系の病変には影響を及ぼさなかった. ASO療法における効果的な薬動学的バイオマーカーについては,さらなる研究が必要である.
科学分野:
- 神経科学
- 遺伝学
- 薬理学について
背景:
- C9orf72関連ALSは,毒性RNAと二ペプチド重複タンパク質 (DPR) を生成するG4C2重複拡張から生じる.
- これらのトランスクリプトを標的とした抗意味オリゴヌクレオチド (ASO) BIIB078による臨床試験は,臨床上の利益がないため中止された.
研究 の 目的:
- BIIB078の中枢神経系 (CNS) の標的の関与を評価する.
- 治療後の脳脊髄液 (CSF) の薬動学的バイオマーカーを特定する.
主な方法:
- BIIB078で治療を受けた患者の脊髄液と死後の中枢神経組織の分析.
- DPR,リン酸化TDP-43,およびタンパク質シグネチャの定量化
- 炎症バイオマーカーとRNase T2の濃度の測定
主要な成果:
- 減少したDPRと炎症バイオマーカー (CCL26) の増加
- 中枢神経組織にBIIB078が広く分布しているが,DPRとpTDP-43は持続している.
- BIIB078レベルと相関するRNase T2増加を除いて,脊髄タンパク質シグネチャーの有意な変化はありません.
結論:
- BIIB078は,分布にもかかわらず,c9ALSにおける中枢神経系の病変に限られた影響を示した.
- この研究は,ASOの有効性の評価のために神経病理学的変化を反映する薬動学的バイオマーカーの必要性を強調しています.
関連する概念動画
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K

